Neoadjuvant sintilimab, albumin-bound paclitaxel, and carboplatin for locally advanced, resectable esophageal squamous cell carcinoma: clinical study and mechanistic exploration

Abstract The survival benefits of neoadjuvant chemotherapy combined with immunotherapy in locally advanced esophageal squamous cell carcinoma (ESCC) remain unclear, with treatment responses varying due to tumor microenvironment (TME) heterogeneity. In this phase II study, 24 patients received neoadj...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Hui Wu, Qi Jiang, Xiaodan Li, Peng Ye, Aizemaiti Rusidanmu, Ning Li, Xiaodong Teng, Qiyue Wang, Yinqi Chen, Dongdong Huang, Yuejun Han, Bingnan Wang, Wenhong Yu, Jian Tao, Jian Ruan, Haiping Jiang
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Portfolio 2026-01-01
Serier:	npj Precision Oncology
Online adgang:	https://doi.org/10.1038/s41698-025-01248-2
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!